Developer docs
API playgroundTry for free, no card

Search company profiles

Cenegenics

Full company profile

uuid0005szs

Namestring
Cenegenics
Legal namestring
Cenegenics (division of BestLife Holdings)
Websiteurl
cenegenics.com
Company typeenum
Private
Founded yearint
1997
Descriptiontext

Cenegenics is a physician-led performance health and age management company founded in 1997 and headquartered in Las Vegas, Nevada, operating as a division of BestLife Holdings. The company delivers a concierge longevity medicine platform that combines 600+ biomarkers (drawn via in-home phlebotomy covering 270+ markers), advanced in-center diagnostics such as DEXA, VO2 Max, CIMT, neurocognitive testing, brain EEG, and 3D musculoskeletal scanning, with ongoing physician-led personalization across nutrition, fitness, nutraceuticals, and metabolic and hormonal optimization. Add-on modules extend the diagnostic surface through AI-analyzed partners: Advanced CCTA via Cleerly, Whole-Body MRI via Prenuvo, and 22,000-gene analysis via New Amsterdam Genomics, alongside Therapeutic Plasma Exchange deployed under a 2026 partnership with MDLifespan and a genetics integration with 3X4 Genetics (Jul 2024).

The commercial model is a hybrid of one-time Performance Health Assessments and recurring Optimize-style memberships, with pricing tailored during a complimentary consultation and HSA/FSA-eligible components. Cenegenics monetizes a distributed consumer base of 50,000+ lifetime members through 27 centers (20 U.S. and 7 international across Greece, Colombia, Portugal, Mexico, Kenya, Brazil, plus Puerto Rico), 40+ affiliated physicians, and a mobile phlebotomy layer that meets members at home or office. Customer acquisition spans content marketing, paid search, social, and PR features in Vogue, CNBC, GQ, Men's Health, and Fox News.

The recent strategic agenda has centered on capability and channel expansion: a Jan 2026 MDLifespan Therapeutic Plasma Exchange partnership followed by serial TPE launches in Beverly Hills (Feb 2026) and Miami (Apr 2026); the Jun 2026 acquisition and integration of Mayo Clinic-trained Human Sync bringing a Chief Health Officer executive-health model; and continued build-out of a preferred-diagnostic partner ecosystem. The reported outcomes — 2.6 years average biological age reversal per year on program, 17.4% body fat reduction, 31 biomarkers moved into optimal range, and an average 7-year member tenure — describe a high-retention, high-ticket consumer health business operating in the longevity medicine category it pioneered.

Short descriptiontext

Cenegenics is a physician-led concierge longevity medicine practice offering 600+-biarker performance health assessments, ongoing Optimize membership programs, and AI-analyzed specialty diagnostics across 27 centers in the U.S. and internationally for HNW adults seeking biological age reversal.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLas Vegas, United States
HQ citystring
Las Vegas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices26 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
performance health services, longevity medicine, age management programs, biomarker diagnostics, concierge healthcare
NAICS code1 code
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Longevity Medicine
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Membership-Based Performance Health Program
TypeSubscription Recurring
Description

Ongoing membership program providing comprehensive testing, physician-led consultations, personalized nutrition, fitness training, nutraceuticals, metabolic and hormonal optimization, and quarterly biomarker monitoring. Performance Health Assessment priced separately from ongoing membership.

cenegenics.com
2Performance Health Assessment
TypeOne Time License
Description

One-time comprehensive diagnostic evaluation including concierge phlebotomy, DEXA scan, VO2 Max, CIMT, neurocognitive testing, and physician consultation. Core entry point for new members.

cenegenics.com
3Diagnostic Add-On Services
TypeSubscription Recurring
Description

Optional advanced diagnostics including Whole-Body MRI (Prenuvo), Advanced CCTA (Cleerly), Advanced Genomics (New Amsterdam Genomics), and additional lab testing for deeper clinical insight

cenegenics.com
4Nutraceutical Products
TypeSubscription Recurring
Description

Pharmaceutical-grade supplementation recommendations and products tailored to individual deficiency profiles, delivered monthly as part of ongoing program

cenegenics.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details3 tiers
1Optimize Core Program - Extensive testing and diagnostics with physician-led analysis
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing discussed during complimentary consultation; includes concierge phlebotomy (270+ biomarkers), DEXA, VO2 Max, CIMT, CNS Testing, brain EEG, 3D MSK Scan, physician consultation, and quarterly monitoring

cenegenics.com
2Diagnostic Add-Ons - Advanced imaging and genomics
ModelSubscriptionBilling cadenceAnnual
Notes

Advanced CCTA analyzed by Cleerly AI platform; Whole-Body MRI by Prenuvo; Advanced Genomics by New Amsterdam Genomics - all optional add-ons for deeper clinical insight

cenegenics.com
3Lab Add-Ons - Additional biomarker testing
ModelSubscriptionBilling cadenceAnnual
Notes

Advanced Genomics, Micronutrient Analysis, Food Allergy and Sensitivity Testing, NutriGenomic and Epigenetic Testing available as optional add-ons

cenegenics.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Cenegenics delivers a physician-led performance health and age management program built around comprehensive biomarker analysis (600+ metrics), in-center advanced diagnostics (DEXA, VO2 Max, CIMT, neurocognitive testing, brain EEG, 3D musculoskeletal scanning), and ongoing personalized intervention plans covering nutrition, fitness, nutraceuticals, and hormone optimization. The offering is structured as an annual membership with a one-time Performance Health Assessment as the diagnostic entry point, supplemented by optional add-on diagnostics and at-home concierge phlebotomy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Members reverse biological age by average 2.6 years per year on program
+7 more records
Product overview1 text field

Cenegenics offers a unified performance health platform built around its core Optimize program and Performance Health Assessment. The Optimize program is the primary membership offering combining comprehensive biomarker testing (600+ metrics), in-center performance diagnostics (DEXA, VO2 Max, CIMT, neurocognitive testing), and ongoing physician-led coaching. The Performance Health Assessment serves as the diagnostic entry point establishing health baselines. Optional add-on tiers provide deeper clinical insight: Diagnostic Add-Ons include Advanced CCTA (AI-analyzed by Cleerly) and Whole-Body MRI (via Prenuvo); Lab Add-Ons include Advanced Genomics (via New Amsterdam Genomics), Micronutrient/Food Sensitivity Testing, and Therapeutic Plasma Exchange (via MDLifespan partnership). The portfolio is architecturally a platform-plus-modules model where the core program is required and add-ons extend into specialized diagnostics.

Product and service9 records
1Optimize Performance Health Program
CategoryMembership Health Program
Description

The flagship annual performance health membership program combining 600+ biomarker analysis, advanced performance diagnostics, and physician-led personalized intervention including nutrition, fitness training, nutraceuticals, and metabolic/hormonal optimization. Includes concierge phlebotomy at home/office and quarterly biomarker monitoring for adults seeking to optimize healthspan.

2Performance Health Assessment
CategoryDiagnostic Assessment
Description

Comprehensive one-time diagnostic starting point including concierge phlebotomy (270+ biomarkers), health history assessment, physician consultation, DEXA scan, VO2 Max, carotid ultrasound (CIMT), neurocognitive testing, biological age calculation (TallyAge and PhenoAge), and Cenegenics Health Score.

3Advanced CCTA (Coronary CT Angiography)
CategoryDiagnostic Add-On
Description

Diagnostic imaging evaluation analyzed by Cleerly AI platform for detailed analysis of plaque composition and cardiovascular risk beyond standard imaging.

4Whole-Body MRI
CategoryDiagnostic Add-On
Description

Fast, non-invasive full-body scan by Prenuvo for early detection of cancer, aneurysms, and other diseases before symptoms appear.

5Advanced Genomics
CategoryDiagnostic Add-On
Description

Analysis of all 22,000 genes using New Amsterdam Genomics validated AI platform to surface genetic risk factors, medication sensitivities, and variants with bearing on healthspan.

6Micronutrient and Food Sensitivity Testing
CategoryLab Add-On
Description

Lab add-on testing cellular levels of vitamins, minerals, and antioxidants, and identifying immunologic response to various foods.

7Therapeutic Plasma Exchange
CategoryTherapeutic Add-On
Description

Advanced Serial Therapeutic Plasma Exchange protocols using MDLifespan's PlasmaXchange technology. Multi-session physician-supervised plasma exchange combined with environmental toxin diagnostics and biomarker tracking.

83D Musculoskeletal (MSK) Scan
CategoryDiagnostic Add-On
Description

3D analysis of over 1 million data points mapping the body's musculoskeletal structure, movement patterns, and injury risk zones. Available at select centers.

9Brain EEG
CategoryDiagnostic Add-On
Description

Measure of brain's physiological electrical response used to assess neurological performance and evoked potential in real time. Available at select centers.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-26
Description

Mayo Clinic-trained clinical team integrated into Cenegenics, bringing Chief Health Officer model for executive health and longevity. Human Sync Founder Brad Pierce and co-founder Erik Nelson join Cenegenics clinical leadership. Both organizations built on continuous expert-led relationships.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-22
Description

MDLifespan, a physician-led medical technology company and certified Public Benefit Corporation, partnered with Cenegenics to expand Therapeutic Plasma Exchange (TPE) across U.S. centers. MDLifespan provides its patented PlasmaXchange protocols; Cenegenics provides clinical facilities and physician oversight. Initial locations include Beverly Hills, Miami, and Atlanta. MDLifespan claims PlasmaXchange outperforms standard TPE by more than 300%.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-07-19
Description

Partnership integrates 3X4 Genetics testing into Cenegenics health assessment and wellness programs. Clients receive a Blueprint Report identifying unique genetic pathways, enabling clinicians to fine-tune care plans tailored to each client's genetic profile. Aims to advance integration of genetics into clinical practice.

Strategic tierPreferredTypeTechnology or Integration
Description

Diagnostic partner for Whole-Body MRI offering fast, non-invasive full-body scan for early detection of cancer, aneurysms, and other diseases. Award-winning technology from Prenuvo.

Strategic tierPreferredTypeTechnology or Integration
Description

Diagnostic partner for Advanced Coronary CT Angiography (CCTA) analyzed by Cleerly's clinically validated AI platform. Shows plaque composition and cardiovascular risk at detail standard imaging cannot achieve.

6New Amsterdam Genomics
Strategic tierPreferredTypeTechnology or Integration
Description

Diagnostic partner for Advanced Genomics analyzing all 22,000 genes using validated AI platform. Surfaces genetic risk factors, medication sensitivities, and variants with bearing on healthspan.

cenegenics.com
Strategic tierPreferredTypeTechnology or Integration
Description

Diagnostic partner for epigenetic testing and biological age assessment.

Strategic tierPreferredTypeTechnology or Integration
Description

Diagnostic partner for glycan-based age assessment.

Strategic tierPreferredTypeTechnology or Integration
Description

Laboratory partner for specialized nutritional and cellular testing.

Strategic tierPreferredTypeTechnology or Integration
Description

Laboratory partner for comprehensive biomarker testing.

Strategic tierPreferredTypeTechnology or Integration
Description

Healthcare technology partner for diagnostic imaging and clinical equipment.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Membership-based direct-to-consumer platform offering 100+ lab biomarkers and personalized health insights. Direct competitor to Cenegenics in the premium preventive diagnostics and longevity category, though typically at a lower price point and digital-first delivery model.

TypeDirect peer
Description

Pioneer in personal biomarker analysis and longevity insights, combining blood testing with proprietary algorithms. Comparable to Cenegenics in biomarker-centric optimization and target customer of health-conscious adults, but delivered primarily through partnerships and digital channels rather than physician-led centers.

TypeDirect peer
Description

Premium longevity-focused health network offering advanced diagnostics, AI imaging, and personalized healthspan programs at flagship centers. Closely comparable to Cenegenics in concierge longevity positioning, physician-led model, and use of whole-body MRI and advanced cardiac imaging.

TypeDirect peer
Description

Founded by Craig Venter, HLI offers comprehensive genomic, imaging, and clinical assessments focused on healthspan and preventive health. Direct peer in the premium longevity diagnostics space with similar biomarker-and-imaging-led value proposition aimed at HNW individuals.

TypeDirect peer
Description

Multi-location longevity and wellness optimization clinics offering IV therapy, hormone optimization, advanced diagnostics, and aesthetic services. Closely comparable to Cenegenics in the concierge longevity clinic format, member-based pricing, and physician-supervised protocols.

6Modern Age
TypeEmerging player
Description

Smaller-scale longevity clinic focused on skin, hair, hormones, and wellness with a digital front door. Comparable in the longevity optimization niche but with narrower scope, fewer diagnostics, and lower price point than Cenegenics.

TypeEmerging player
Description

Direct-to-consumer hormone optimization and longevity platform with telemedicine-led delivery. Overlaps with Cenegenics on hormone therapy and biomarker-driven care for men over 35, but delivers care remotely rather than through physical centers.

TypeBroad incumbent
Description

Large-scale nutritional supplement brand with growing health testing and personalization capabilities. Comparable to Cenegenics in nutraceutical product sales and biomarker-guided supplementation, but operates at much broader scale and lower price points.

TypeEmerging player
Description

Whole-body MRI screening service for early cancer and disease detection, offered both standalone and as a Cenegenics preferred diagnostic partner. Partially overlapping in longevity screening customer base but narrower in scope (imaging only).

TypeOthers
Description

Large diagnostic laboratory services company and one of Cenegenics' preferred lab partners for comprehensive biomarker testing. Adjacent ecosystem participant rather than a competitor, providing infrastructure that enables Cenegenics' testing model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key highlights8 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cenegenics

Longevity Medicinecenegenics.com

Cenegenics is a physician-led concierge longevity medicine practice offering 600+-biarker performance health assessments, ongoing Optimize membership programs, and AI-analyzed specialty diagnostics across 27 centers in the U.S. and internationally for HNW adults seeking biological age reversal.

What Cenegenics does

Cenegenics is a physician-led performance health and age management company founded in 1997 and headquartered in Las Vegas, Nevada, operating as a division of BestLife Holdings. The company delivers a concierge longevity medicine platform that combines 600+ biomarkers (drawn via in-home phlebotomy covering 270+ markers), advanced in-center diagnostics such as DEXA, VO2 Max, CIMT, neurocognitive testing, brain EEG, and 3D musculoskeletal scanning, with ongoing physician-led personalization across nutrition, fitness, nutraceuticals, and metabolic and hormonal optimization. Add-on modules extend the diagnostic surface through AI-analyzed partners: Advanced CCTA via Cleerly, Whole-Body MRI via Prenuvo, and 22,000-gene analysis via New Amsterdam Genomics, alongside Therapeutic Plasma Exchange deployed under a 2026 partnership with MDLifespan and a genetics integration with 3X4 Genetics (Jul 2024).

The commercial model is a hybrid of one-time Performance Health Assessments and recurring Optimize-style memberships, with pricing tailored during a complimentary consultation and HSA/FSA-eligible components. Cenegenics monetizes a distributed consumer base of 50,000+ lifetime members through 27 centers (20 U.S. and 7 international across Greece, Colombia, Portugal, Mexico, Kenya, Brazil, plus Puerto Rico), 40+ affiliated physicians, and a mobile phlebotomy layer that meets members at home or office. Customer acquisition spans content marketing, paid search, social, and PR features in Vogue, CNBC, GQ, Men's Health, and Fox News.

The recent strategic agenda has centered on capability and channel expansion: a Jan 2026 MDLifespan Therapeutic Plasma Exchange partnership followed by serial TPE launches in Beverly Hills (Feb 2026) and Miami (Apr 2026); the Jun 2026 acquisition and integration of Mayo Clinic-trained Human Sync bringing a Chief Health Officer executive-health model; and continued build-out of a preferred-diagnostic partner ecosystem. The reported outcomes — 2.6 years average biological age reversal per year on program, 17.4% body fat reduction, 31 biomarkers moved into optimal range, and an average 7-year member tenure — describe a high-retention, high-ticket consumer health business operating in the longevity medicine category it pioneered.

Cenegenics firmographics

Firmographics
Name
Cenegenics
Legal name
Cenegenics (division of BestLife Holdings)
Website
https://cenegenics.com
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
101–250 employees
Short description
Cenegenics is a physician-led concierge longevity medicine practice offering 600+-biarker performance health assessments, ongoing Optimize membership programs, and AI-analyzed specialty diagnostics across 27 centers in the U.S. and internationally for HNW adults seeking biological age reversal.
Ownership category
akta.pro rank

Where Cenegenics is headquartered

Location

Headquarters

HQ city
Las Vegas
HQ country
United States
HQ region
North America

Offices26 records

Markets served

Cenegenics business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Membership-Based Performance Health Program: Ongoing membership program providing comprehensive testing, physician-led consultations, personalized nutrition, fitness training, nutraceuticals, metabolic and hormonal optimization, and quarterly biomarker monitoring. Performance Health Assessment priced separately from ongoing membership.
  2. Performance Health Assessment: One-time comprehensive diagnostic evaluation including concierge phlebotomy, DEXA scan, VO2 Max, CIMT, neurocognitive testing, and physician consultation. Core entry point for new members.
  3. Diagnostic Add-On Services: Optional advanced diagnostics including Whole-Body MRI (Prenuvo), Advanced CCTA (Cleerly), Advanced Genomics (New Amsterdam Genomics), and additional lab testing for deeper clinical insight
  4. Nutraceutical Products: Pharmaceutical-grade supplementation recommendations and products tailored to individual deficiency profiles, delivered monthly as part of ongoing program

Pricing tiers

ModelBillingPrice
SubscriptionAnnualOptimize Core Program - Extensive testing and diagnostics with physician-led analysis
SubscriptionAnnualDiagnostic Add-Ons - Advanced imaging and genomics
SubscriptionAnnualLab Add-Ons - Additional biomarker testing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels10 records

Cenegenics product offering

Product offering

Core offering

Cenegenics delivers a physician-led performance health and age management program built around comprehensive biomarker analysis (600+ metrics), in-center advanced diagnostics (DEXA, VO2 Max, CIMT, neurocognitive testing, brain EEG, 3D musculoskeletal scanning), and ongoing personalized intervention plans covering nutrition, fitness, nutraceuticals, and hormone optimization. The offering is structured as an annual membership with a one-time Performance Health Assessment as the diagnostic entry point, supplemented by optional add-on diagnostics and at-home concierge phlebotomy.

Product overview

Cenegenics offers a unified performance health platform built around its core Optimize program and Performance Health Assessment. The Optimize program is the primary membership offering combining comprehensive biomarker testing (600+ metrics), in-center performance diagnostics (DEXA, VO2 Max, CIMT, neurocognitive testing), and ongoing physician-led coaching. The Performance Health Assessment serves as the diagnostic entry point establishing health baselines. Optional add-on tiers provide deeper clinical insight: Diagnostic Add-Ons include Advanced CCTA (AI-analyzed by Cleerly) and Whole-Body MRI (via Prenuvo); Lab Add-Ons include Advanced Genomics (via New Amsterdam Genomics), Micronutrient/Food Sensitivity Testing, and Therapeutic Plasma Exchange (via MDLifespan partnership). The portfolio is architecturally a platform-plus-modules model where the core program is required and add-ons extend into specialized diagnostics.

Differentiator

Problem solved

Functional benefit

Products and services

  • Optimize Performance Health Program The flagship annual performance health membership program combining 600+ biomarker analysis, advanced performance diagnostics, and physician-led personalized intervention including nutrition, fitness training, nutraceuticals, and metabolic/hormonal optimization. Includes concierge phlebotomy at home/office and quarterly biomarker monitoring for adults seeking to optimize healthspan.
  • Performance Health Assessment Comprehensive one-time diagnostic starting point including concierge phlebotomy (270+ biomarkers), health history assessment, physician consultation, DEXA scan, VO2 Max, carotid ultrasound (CIMT), neurocognitive testing, biological age calculation (TallyAge and PhenoAge), and Cenegenics Health Score.
  • Advanced CCTA (Coronary CT Angiography) Diagnostic imaging evaluation analyzed by Cleerly AI platform for detailed analysis of plaque composition and cardiovascular risk beyond standard imaging.
  • Whole-Body MRI Fast, non-invasive full-body scan by Prenuvo for early detection of cancer, aneurysms, and other diseases before symptoms appear.
  • Advanced Genomics Analysis of all 22,000 genes using New Amsterdam Genomics validated AI platform to surface genetic risk factors, medication sensitivities, and variants with bearing on healthspan.
  • Micronutrient and Food Sensitivity Testing Lab add-on testing cellular levels of vitamins, minerals, and antioxidants, and identifying immunologic response to various foods.
  • Therapeutic Plasma Exchange Advanced Serial Therapeutic Plasma Exchange protocols using MDLifespan's PlasmaXchange technology. Multi-session physician-supervised plasma exchange combined with environmental toxin diagnostics and biomarker tracking.
  • 3D Musculoskeletal (MSK) Scan 3D analysis of over 1 million data points mapping the body's musculoskeletal structure, movement patterns, and injury risk zones. Available at select centers.
  • Brain EEG Measure of brain's physiological electrical response used to assess neurological performance and evoked potential in real time. Available at select centers.

Quantifiable outcome

  • Members reverse biological age by average 2.6 years per year on program
  • +7 more outcomes

Companies that use Cenegenics

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Cenegenics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Feature4 records

Cenegenics partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and preferred.

  • Human SynccoreStrategic or Co-development Partner · 26 June 2026Mayo Clinic-trained clinical team integrated into Cenegenics, bringing Chief Health Officer model for executive health and longevity. Human Sync Founder Brad Pierce and co-founder Erik Nelson join Cenegenics clinical leadership. Both organizations built on continuous expert-led relationships.
  • MDLifespancoreStrategic or Co-development Partner · 22 January 2026MDLifespan, a physician-led medical technology company and certified Public Benefit Corporation, partnered with Cenegenics to expand Therapeutic Plasma Exchange (TPE) across U.S. centers. MDLifespan provides its patented PlasmaXchange protocols; Cenegenics provides clinical facilities and physician oversight. Initial locations include Beverly Hills, Miami, and Atlanta. MDLifespan claims PlasmaXchange outperforms standard TPE by more than 300%.
  • 3X4 GeneticscoreTechnology or Integration · 19 July 2024Partnership integrates 3X4 Genetics testing into Cenegenics health assessment and wellness programs. Clients receive a Blueprint Report identifying unique genetic pathways, enabling clinicians to fine-tune care plans tailored to each client's genetic profile. Aims to advance integration of genetics into clinical practice.
  • PrenuvopreferredTechnology or IntegrationDiagnostic partner for Whole-Body MRI offering fast, non-invasive full-body scan for early detection of cancer, aneurysms, and other diseases. Award-winning technology from Prenuvo.
  • CleerlypreferredTechnology or IntegrationDiagnostic partner for Advanced Coronary CT Angiography (CCTA) analyzed by Cleerly's clinically validated AI platform. Shows plaque composition and cardiovascular risk at detail standard imaging cannot achieve.
  • New Amsterdam GenomicspreferredTechnology or IntegrationDiagnostic partner for Advanced Genomics analyzing all 22,000 genes using validated AI platform. Surfaces genetic risk factors, medication sensitivities, and variants with bearing on healthspan.
  • Tru-DiagnosticpreferredTechnology or IntegrationDiagnostic partner for epigenetic testing and biological age assessment.
  • GlycanAgepreferredTechnology or IntegrationDiagnostic partner for glycan-based age assessment.
  • Spectra Cell LaboratoriespreferredTechnology or IntegrationLaboratory partner for specialized nutritional and cellular testing.
  • Quest DiagnosticspreferredTechnology or IntegrationLaboratory partner for comprehensive biomarker testing.
  • GE HealthcarepreferredTechnology or IntegrationHealthcare technology partner for diagnostic imaging and clinical equipment.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Cenegenics competitors and assessment

Company assessment

Direct peers

  • Function Health: Membership-based direct-to-consumer platform offering 100+ lab biomarkers and personalized health insights. Direct competitor to Cenegenics in the premium preventive diagnostics and longevity category, though typically at a lower price point and digital-first delivery model.
  • InsideTracker: Pioneer in personal biomarker analysis and longevity insights, combining blood testing with proprietary algorithms. Comparable to Cenegenics in biomarker-centric optimization and target customer of health-conscious adults, but delivered primarily through partnerships and digital channels rather than physician-led centers.
  • Fountain Life: Premium longevity-focused health network offering advanced diagnostics, AI imaging, and personalized healthspan programs at flagship centers. Closely comparable to Cenegenics in concierge longevity positioning, physician-led model, and use of whole-body MRI and advanced cardiac imaging.
  • Human Longevity Inc. Founded by Craig Venter, HLI offers comprehensive genomic, imaging, and clinical assessments focused on healthspan and preventive health. Direct peer in the premium longevity diagnostics space with similar biomarker-and-imaging-led value proposition aimed at HNW individuals.
  • Next Health: Multi-location longevity and wellness optimization clinics offering IV therapy, hormone optimization, advanced diagnostics, and aesthetic services. Closely comparable to Cenegenics in the concierge longevity clinic format, member-based pricing, and physician-supervised protocols.

Emerging players

  • Modern Age: Smaller-scale longevity clinic focused on skin, hair, hormones, and wellness with a digital front door. Comparable in the longevity optimization niche but with narrower scope, fewer diagnostics, and lower price point than Cenegenics.
  • Hone Health: Direct-to-consumer hormone optimization and longevity platform with telemedicine-led delivery. Overlaps with Cenegenics on hormone therapy and biomarker-driven care for men over 35, but delivers care remotely rather than through physical centers.
  • Prenuvo: Whole-body MRI screening service for early cancer and disease detection, offered both standalone and as a Cenegenics preferred diagnostic partner. Partially overlapping in longevity screening customer base but narrower in scope (imaging only).

Broad incumbents

  • Thorne: Large-scale nutritional supplement brand with growing health testing and personalization capabilities. Comparable to Cenegenics in nutraceutical product sales and biomarker-guided supplementation, but operates at much broader scale and lower price points.

Others

  • Quest Diagnostics: Large diagnostic laboratory services company and one of Cenegenics' preferred lab partners for comprehensive biomarker testing. Adjacent ecosystem participant rather than a competitor, providing infrastructure that enables Cenegenics' testing model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights8 records

Customer concentration

Cenegenics social profiles

Digital presence

Cenegenics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cenegenics leadership team

Management profile

Number of profiles

Profiles5 records

Cenegenics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cenegenics M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cenegenics

What does Cenegenics do?

Cenegenics delivers a physician-led performance health and age management program built around comprehensive biomarker analysis (600+ metrics), in-center advanced diagnostics (DEXA, VO2 Max, CIMT, neurocognitive testing, brain EEG, 3D musculoskeletal scanning), and ongoing personalized intervention plans covering nutrition, fitness, nutraceuticals, and hormone optimization. The offering is structured as an annual membership with a one-time Performance Health Assessment as the diagnostic entry point, supplemented by optional add-on diagnostics and at-home concierge phlebotomy.

Is Cenegenics a public or private company?

Cenegenics is a private company. It is classified as corporate owned and is currently operating.

When was Cenegenics founded?

Cenegenics was founded in 1997. It employs 101 to 250 people.

Where is Cenegenics based?

Cenegenics is headquartered in Las Vegas, United States, in the North America region.

How does Cenegenics make money?

Four revenue lines are on record. Membership-Based Performance Health Program is the primary driver. The others are performance Health Assessment, diagnostic Add-On Services and nutraceutical Products.

Who are Cenegenics's main competitors?

Direct peers on record are Function Health, InsideTracker, Fountain Life, Human Longevity Inc. and Next Health. Emerging players are Modern Age, Hone Health and Prenuvo. Thorne is listed as a broad incumbent. Quest Diagnostics is listed as an others.

Does Cenegenics have an API?

No public API is recorded for Cenegenics.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Longevity.TechnologyAman Clinics launches Cenegenics’ longevity model in QatarAman Clinics, a Doha-based healthcare provider, has launched Cenegenics' physician-led longevity and precision health program in Qatar, becoming the first healthcare provider in the region to offer this methodology. The partnership enables Cenegenics, a longevity and performance medicine company with nearly three decades of experience across five continents, to expand its international footprint into the Gulf region. The program focuses on preventive care through advanced biomarker analysis, genomic profiling, and personalized health assessments, aiming to detect health risks before symptoms appear rather than treating existing illness.Longevity.TechnologyAman Clinics partners with Cenegenics to launch Qatar’s first healthy aging center in DohaAman Clinics, a subsidiary of Aman Hospital and wholly owned by Jaidah Holdings, announced a strategic partnership with Cenegenics on July 27, 2026, to open Cenegenics at its Msheireb Downtown Doha clinic, marking Qatar's first healthy aging center. The Cenegenics clinical model utilizes advanced testing, genomic profiling, biomarker evaluation, and clinical assessments to create personalized, physician-led health optimization plans backed by nearly 30 years of clinical outcomes.PR NewswireAman Clinics Introduces the World-Renowned Cenegenics Precision Medicine & Longevity Program to Qatar and the RegionAman Clinics, a subsidiary of Aman Hospital, announced a strategic partnership with Cenegenics, the global leader in longevity and performance medicine, to launch the Cenegenics precision health program at its facility in Doha, Qatar. The program, which uses advanced testing, genomic profiling, and biomarker evaluation to create personalized health optimization plans, marks the first time this methodology has been available in Qatar and the wider region. The partnership reflects both companies' commitment to advancing proactive, data-driven healthcare and setting a new standard for preventive medicine in the Gulf.CenegenicsCenegenics integrates Human Sync, Deepening its Physician-led Longevity ModelCenegenics integrated Human Sync, a Mayo Clinic–trained clinical practice for executives, adding Erik Nelson to its clinical leadership. The integration deepens physician-led longevity care, with both organizations built on continuous, relationship-based health management.EIN PresswireCenegenics Announces Integration of Human Sync, a Leading Private Healthcare and Longevity Medicine CompanyCenegenics announced the integration of Human Sync, a private healthcare and longevity medicine practice, into its clinical capabilities. Human Sync's protocols and clinical expertise will be incorporated, and co-founder Erik Nelson will join Cenegenics' clinical leadership team. The integration aims to strengthen Cenegenics' approach to personalized performance health and preventive medicine.EIN PresswireLos Angeles Fires Spark Growing Concerns Around Toxic Exposure and InflammationMDLifespan and Cenegenics Beverly Hills will host a free virtual webinar on June 9, 2026, addressing environmental toxins and inflammation after the Los Angeles fires. The event, led by Dr. Paul Savage, covers toxic burden, exposure sources, and Advanced Serial Therapeutic Plasma Exchange (TPE) as a physician-led detox approach.Main Line TodayMain Line Area Experts Take a Fresh Approach to AgingHealthcare experts in Pennsylvania's Main Line area are describing a shift in medicine from reactive disease treatment to preventive, data-driven longevity approaches focused on extending healthspan—the quality of years lived rather than just lifespan. The article highlights strength training, muscle preservation, metabolic health monitoring, sleep, and nutrition as key factors, with experts identifying midlife as a pivotal decade for intervention. Clinics like Cenegenics, RYEZ Healthspan, and The Movement Paradigm are cited as examples of practices offering personalized physician-led health management plans that assess early risk markers beyond standard lab ranges.Business InsiderAdvanced Serial Plasma Exchange Now Available in Miami as Environmental Toxin Concerns Rise Across South FloridaMDLifespan announced the launch of its Advanced Therapeutic Plasma Exchange protocols at Cenegenics Miami in Coral Gables, marking the medical technology company's expansion into South Florida through a clinical partnership with a physician-led performance health center. The integration provides multi-session, physician-supervised plasma exchange protocols combined with advanced biomarker analysis and environmental toxin diagnostics, targeting individuals concerned about circulating toxin burden from South Florida's documented water and coastal pollution. MDLifespan, founded by Dr. Paul Savage and structured as a certified Public Benefit Corporation, plans to use this launch to support its national expansion strategy of partnering with established physician-led clinics.Longevity.TechnologyCenegenics expands advanced plasma exchange services in Beverly HillsCenegenics Medical Institute has expanded advanced plasma exchange services at its Beverly Hills location, using patented technology to selectively remove circulating inflammatory proteins, metabolic byproducts, and environmental toxins while retaining beneficial plasma components. The company positions the offering as part of a broader wellness-oriented precision medicine suite targeting individuals seeking preventative health strategies, though it clarifies that plasma exchange is not a disease-specific therapy. The expansion reflects growing patient interest in innovative approaches to address chronic environmental stressors and systemic inflammation.PR NewswireAdvanced Serial Plasma Exchange Arrives in Beverly Hills as Los Angeles Faces Rising Environmental Health ConcernsMDLifespan, a physician-led medical technology company and Public Benefit Corporation, announced the launch of its Advanced Serial Therapeutic Plasma Exchange protocols at Cenegenics Beverly Hills, expanding access to personalized toxin reduction and biomarker-driven care in Los Angeles. The integration adapts hospital-based therapeutic plasma exchange into a standardized outpatient protocol model designed to address environmental exposure concerns including wildfire particulate, air pollution, and chemical contaminants. The Beverly Hills launch supports MDLifespan's national expansion strategy through strategic clinical partnerships with established physician-led clinics.